EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeted sequencing of DNA/RNA combined with radiomics predicts lymph node metastasis of papillary thyroid carcinoma

Runjiao Zhang, Linfei Hu, Yanan Cheng, Luchen Chang, Li Dong, Lei Han, Wenwen Yu, Rui Zhang, Pengpeng Liu, Xi Wei, Jinpu Yu

Cancer Imaging · 2024

DOI: 10.1186/s40644-024-00719-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Imaging, 2024. Verfasst von Runjiao Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Molecular Diagnostics Core, Key Laboratory of Cancer Immunology and Biotherapy, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medic…. Hauptthemen laut MEDLINE: Lymphatic Metastasis, Thyroid Cancer, Papillary, Thyroid Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Science and Technology Support Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The aim of our study is to find a better way to identify a group of papillary thyroid carcinoma (PTC) with more aggressive behaviors and to provide a prediction model for lymph node metastasis to assist in clinic practice.

Methods

Targeted sequencing of DNA/RNA was used to detect genetic alterations. Gene expression level was measured by quantitative real-time PCR, western blotting or immunohistochemistry. CCK8, transwell assay and flow cytometry were used to investigate the effects of concomitant gene alterations in PTC. LASSO-logistics regression algorithm was used to construct a nomogram model integrating radiomic features, mutated genes and clinical characteristics.

Results

172 high-risk variants and 7 fusion types were detected. The mutation frequencies in BRAF , TERT , RET , ATM and GGT1 were significantly higher in cancer tissues than benign nodules. Gene fusions were detected in 16 samples (2 at the DNA level and 14 at the RNA level). ATM mutation ( ATM MUT ) was frequently accompanied by BRAF MUT , TERT MUT or gene fusions. ATM MUT alone or ATM co-mutations were significantly positively correlated with lymph node metastasis. Accordingly, ATM knock-down PTC cells bearing BRAF V600E , KRAS G12R or CCDC6-RET had higher proliferative ability and more aggressive potency than cells without ATM knock-down in vitro. Furthermore, combining gene alterations and clinical features significantly improved the predictive efficacy for lymph node metastasis of radiomic features, from 71.5 to 87.0%.

Conclusions

Targeted sequencing of comprehensive genetic alterations in PTC has high prognostic value. These alterations, in combination with clinical and radiomic features, may aid in predicting invasive PTC with higher accuracy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphatic MetastasisThyroid Cancer, PapillaryThyroid NeoplasmsHumansMaleFemaleMiddle AgedMutationAdultProto-Oncogene Proteins B-rafAtaxia Telangiectasia Mutated ProteinsNomogramsBiomarkers, TumorTelomeraseRadiomics

Stichwörter der Autor:innen

Clinical applicationDNA damage repairMutationNext generation sequencingPredictive modelThyroid carcinomaUltrasonography

Substanzen

Proto-Oncogene Proteins B-rafBRAF protein, humanAtaxia Telangiectasia Mutated ProteinsBiomarkers, TumorTelomeraseTERT protein, human

Autor:innen und Institutionen

  • Cancer Molecular Diagnostics Core, Key Laboratory of Cancer Immunology and Biotherapy, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Researc…
  • Tianjin's Clinical Research Center for Cancer, Tianjin, China.
  • Department of Thyroid and Neck Tumor, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
  • Department of Diagnostic and Therapeutic Ultrasonography, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin,…
  • Department of Immunology, Key Laboratory of Cancer Immunology and Biotherapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for…
  • Tianjin's Clinical Research Center for Cancer, Tianjin, China. weixi@tmu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • National Science and Technology Support Program of China

Zitieren

APA

Zhang, R., Hu, L., Cheng, Y., Chang, L., Dong, L., Han, L., Yu, W., Zhang, R., Liu, P., Wei, X., & Yu, J. (2024). Targeted sequencing of DNA/RNA combined with radiomics predicts lymph node metastasis of papillary thyroid carcinoma. Cancer Imaging. https://doi.org/10.1186/s40644-024-00719-2

Vancouver

Zhang R, Hu L, Cheng Y, Chang L, Dong L, Han L, et al. Targeted sequencing of DNA/RNA combined with radiomics predicts lymph node metastasis of papillary thyroid carcinoma. Cancer Imaging. 2024. doi:10.1186/s40644-024-00719-2

BibTeX
@article{Zhang2024,
  author = {Zhang, Runjiao and Hu, Linfei and Cheng, Yanan and Chang, Luchen and Dong, Li and Han, Lei and Yu, Wenwen and Zhang, Rui and Liu, Pengpeng and Wei, Xi and Yu, Jinpu},
  title = {Targeted sequencing of DNA/RNA combined with radiomics predicts lymph node metastasis of papillary thyroid carcinoma},
  journal = {Cancer Imaging},
  year = {2024},
  doi = {10.1186/s40644-024-00719-2}
}
Kostenlos starten →